Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 971750, 10 pages
http://dx.doi.org/10.1155/2014/971750
Research Article

CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat

Department of Emergency Medicine, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning 110004, China

Received 8 March 2014; Accepted 8 May 2014; Published 22 May 2014

Academic Editor: Stephen C. Land

Copyright © 2014 Zhenning Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Dinis-Oliveira, J. A. Duarte, A. Sánchez-Navarro, F. Remião, M. L. Bastos, and F. Carvalho, “Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment,” Critical Reviews in Toxicology, vol. 38, no. 1, pp. 13–71, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Venkatesan, “Pulmonary protective effects of curcumin against paraquat toxicity,” Life Sciences, vol. 66, no. 2, pp. L-21–L-28, 1999. View at Google Scholar · View at Scopus
  3. S. Kishimoto, M. Muramatsu, M. Gokoh, S. Oka, K. Waku, and T. Sugiura, “Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells,” Journal of Biochemistry, vol. 137, no. 2, pp. 217–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Oka, S. Ikeda, S. Kishimoto et al., “2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils,” Journal of Leukocyte Biology, vol. 76, no. 5, pp. 1002–1009, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Mackie, “Cannabinoid receptors as therapeutic targets,” Annual Review of Pharmacology and Toxicology, vol. 46, pp. 101–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. E. Buckley, “The peripheral cannabinoid receptor knockout mice: an update,” The British Journal of Pharmacology, vol. 153, no. 2, pp. 309–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Bátkai, D. Osei-Hyiaman, H. Pan et al., “Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury,” The FASEB Journal, vol. 21, no. 8, pp. 1788–1800, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Rajesh, P. Mukhopadhyay, S. Bátkai et al., “CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2210–H2218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Montecucco, S. Lenglet, V. Braunersreuther et al., “CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion,” Journal of Molecular and Cellular Cardiology, vol. 46, no. 5, pp. 612–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Bátkai, M. Rajesh, P. Mukhopadhyay et al., “Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 2, pp. H909–H918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Pacher, S. Bátkai, and G. Kunos, “The endocannabinoid system as an emerging target of pharmacotherapy,” Pharmacological Reviews, vol. 58, no. 3, pp. 389–462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pacher and G. Haskó, “Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning,” The British Journal of Pharmacology, vol. 153, no. 2, pp. 252–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Pertwee, “Emerging strategies for exploiting cannabinoid receptor agonists as medicines,” The British Journal of Pharmacology, vol. 156, no. 3, pp. 397–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Mukhopadhyay, M. Rajesh, B. Horváth et al., “Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death,” Free Radical Biology and Medicine, vol. 50, no. 10, pp. 1368–1381, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. N. Liu, M. Zhao, Q. Zheng, H. Y. Zhao, W. J. Hou, and S. L. Bai, “Inhibitory effects of rosiglitazone on paraquat-induced acute lung injury in rats,” Acta Pharmacologica Sinica, vol. 34, no. 10, pp. 1317–1324, 2013. View at Google Scholar
  16. H. Yin, X. B. Jin, Q. Gong et al., “Fructose-1,6-diphosphate attenuates acute lung injury induced by lipopolysaccharide in mice,” International Immunopharmacology, vol. 8, no. 13-14, pp. 1842–1847, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Guidot, H. G. Folkesson, L. Jain, J. I. Sznajder, J. Pittet, and M. A. Matthay, “Integrating acute lung injury and regulation of alveolar fluid clearance,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 291, no. 3, pp. L301–L306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. E. Orfanos, I. Mavrommati, I. Korovesi, and C. Roussos, “Pulmonary endothelium in acute lung injury: from basic science to the critically ill,” Intensive Care Medicine, vol. 30, no. 9, pp. 1702–1714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Rojas, C. R. Woods, A. L. Mora, J. Xu, and K. L. Brigham, “Endotoxin-induced lung injury in mice: structural, functional, and biochemical responses,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 288, no. 2, pp. L333–L341, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. R. K. Albert, D. Leasa, M. Sanderson, H. T. Robertson, and M. P. Hlastala, “The prone position improves arterial oxygenation and reduces shunt in oleic-acid-induced acute lung injury,” The American Review of Respiratory Disease, vol. 135, no. 3, pp. 628–633, 1987. View at Google Scholar · View at Scopus
  21. M. Cepkova and M. A. Matthay, “Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome,” Journal of Intensive Care Medicine, vol. 21, no. 3, pp. 119–143, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. J. Klebanoff, “Myeloperoxidase: friend and foe,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 598–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. F. Guo, A. B. Lentsch, R. L. Warner et al., “Regulatory effects of eotaxin on acute lung inflammatory injury,” Journal of Immunology, vol. 166, no. 8, pp. 5208–5218, 2001. View at Google Scholar · View at Scopus
  24. Y. Ishida, T. Takayasu, A. Kimura et al., “Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice,” Legal Medicine, vol. 8, no. 2, pp. 102–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Amirshahrokhi and S. Bohlooli, “Effect of methylsulfonylmethane on paraquat-induced acute lung and liver injury in mice,” Inflammation, vol. 36, no. 5, pp. 1111–1121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Q. Zhang, H. D. Wang, D. X. Lu et al., “Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the α2-adrenergic receptor in mice,” Shock, vol. 29, no. 5, pp. 617–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Roux, H. Kawakatsu, B. Gartland et al., “Interleukin-1β decreases expression of the epithelial sodium channel α-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway,” The Journal of Biological Chemistry, vol. 280, no. 19, pp. 18579–18589, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. B. M. Hybertson, Y. M. Lee, H. G. Cho, O. J. Cho, and J. E. Repine, “Alveolar type II cell abnormalities and peroxide formation in lungs of rats given IL-1 intratracheally,” Inflammation, vol. 24, no. 4, pp. 289–303, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. M. Lee, B. M. Hybertson, H. G. Cho et al., “Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 1, pp. L75–L80, 2000. View at Google Scholar · View at Scopus
  30. A. B. Lentsch and P. A. Ward, “Activation and regulation of NFκB during acute inflammation,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 3, pp. 205–208, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Hawiger, “Innate immunity and inflammation: a transcriptional paradigm,” Immunologic Research, vol. 23, no. 2-3, pp. 99–109, 2001. View at Google Scholar · View at Scopus
  32. T. Huxford and G. Ghosh, “A structural guide to proteins of the NF-κB signaling module,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 3, Article ID a000075, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. P. A. Baeuerle and V. R. Baichwal, “NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules,” Advances in Immunology, vol. 65, pp. 111–137, 1997. View at Google Scholar · View at Scopus
  34. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Google Scholar · View at Scopus
  35. M. Guha and N. Mackman, “LPS induction of gene expression in human monocytes,” Cellular Signalling, vol. 13, no. 2, pp. 85–94, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. A. K. Lee, S. H. Sung, Y. C. Kim, and S. G. Kim, “Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κB α phosphorylation, C/EBP and AP-1 activation,” The British Journal of Pharmacology, vol. 139, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar
  37. J. J. Baldassare, Y. Bi, and C. J. Bellone, “The role of p38 mitogen-activated protein kinase in IL-1β transcription,” Journal of Immunology, vol. 162, no. 9, pp. 5367–5373, 1999. View at Google Scholar · View at Scopus
  38. E. Hitti, T. Iakovleva, M. Brook et al., “Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element,” Molecular and Cellular Biology, vol. 26, no. 6, pp. 2399–2407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Patil, X. Zhu, C. Rossa Jr., Y. J. Kim, and K. L. Kirkwood, “p38 MAPK regulates IL-1β induced IL-6 expression through mRNA stability in osteoblasts,” Immunological Investigations, vol. 33, no. 2, pp. 213–233, 2004. View at Google Scholar · View at Scopus
  40. Z. Han, D. L. Boyle, L. Chang et al., “c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis,” Journal of Clinical Investigation, vol. 108, no. 1, pp. 73–81, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. W. H. Park, “The effect of MAPK inhibitors and ROS modulators on cell growth and death of H2O2-treated HeLa cells,” Molecular Medicine Reports, vol. 8, no. 2, pp. 557–564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Zeng, N. Feirt, M. Goldstein et al., “Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice,” Hepatology, vol. 39, no. 2, pp. 422–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. I. N. Hines and M. B. Grisham, “Divergent roles of superoxide and nitric oxide in liver ischemia and reperfusion injury,” Journal of Clinical Biochemistry and Nutrition, vol. 48, no. 1, pp. 50–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Abe, I. N. Hines, G. Zibari et al., “Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo,” Free Radical Biology and Medicine, vol. 46, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Cindrova-Davies, “Gabor Than award lecture 2008: pre-eclampsia—from placental oxidative stress to maternal endothelial dysfunction,” Placenta, vol. 30, supplement, pp. S55–S65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Pearson, F. Robinson, T. B. Gibson et al., “Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions,” Endocrine Reviews, vol. 22, no. 2, pp. 153–183, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., “A protein kinase involved in the regulation of inflammatory cytokine biosynthesis,” Nature, vol. 372, no. 6508, pp. 739–746, 1994. View at Google Scholar · View at Scopus
  48. J. Tan, D. Liu, X. Lv et al., “MAPK mediates inflammatory response and cell death in rat pulmonary microvascular endothelial cells in an ischemia-reperfusion model of lung transplantation,” Journal of Heart and Lung Transplantation, vol. 32, no. 8, pp. 823–831, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Pacher and R. Mechoulam, “Is lipid signaling through cannabinoid 2 receptors part of a protective system?” Progress in Lipid Research, vol. 50, no. 2, pp. 193–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Ribeiro, J. Wen, S. Li, and Y. Zhang, “Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists,” Prostaglandins and Other Lipid Mediators, vol. 100-101, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Gertsch, M. Leonti, S. Raduner et al., “Beta-caryophyllene is a dietary cannabinoid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9099–9104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Aso, S. Juvés, R. Maldonado, and I. Ferrer, “CB2 cannabinoid receptor agonist ameliorates alzheimer-like phenotype in AβPP/PS1 mice,” Journal of Alzheimer's Disease, vol. 35, no. 4, pp. 847–858, 2013. View at Publisher · View at Google Scholar · View at Scopus